| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Gefitinib | FIMM | pan-cancer | AAC | 0.21 | 0.4 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | 0.048 | 0.4 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | -0.035 | 0.4 |